Merck Animal Health Gets FDA Approval of Bravecto Monthly Chews
July 09 2020 - 5:40PM
Dow Jones News
By Stephen Nakrosis
Merck Animal Health said Thursday the U.S. Food and Drug
Administration gave approval for its Bravecto one-month chews for
dogs and puppies 8 weeks and older.
The company said its Bravecto, or fluralaner, chews are
"administered as a single, monthly flavored chew formulation for
treatment and prevention of fleas and treatment and control of
ticks."
The company also said pet owners can transition their dogs to
its extended duration Bravecto products at 6 months of age,
"helping to ensure consistent treatment and compliance."
Merck Animal Health, which is known as MSD Animal Health outside
the U.S. and Canada, is a division of Merck & Co., Inc.
--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
July 09, 2020 17:25 ET (21:25 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Merck (NYSE:MRK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Merck (NYSE:MRK)
Historical Stock Chart
From Apr 2023 to Apr 2024
